ADMA BIOLOGICS, INC. Notes Payable, Noncurrent
ADMA BIOLOGICS, INC. (ADMA) had Notes Payable, Noncurrent of $93.41 million as of 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities › Notes and Loans, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2021-05-12
- 2021-03-31: Notes Payable, Noncurrent $93.41M.
- 2020-12-31: Notes Payable, Noncurrent $92.97M.
- 2020-09-30: Notes Payable, Noncurrent $82.11M.
- 2020-06-30: Notes Payable, Noncurrent $81.65M.
| Period end | Notes Payable, Noncurrent | Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2021-03-31 | $93.41M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $92.97M 10-Q · filed 2021-05-12 | |
| 2020-09-30 | $82.11M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $81.65M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $81.21M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $68.29M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $67.84M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $67.47M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $40.89M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $26.44M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $26.15M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $25.88M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $25.62M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $25.37M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $14.53M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $9.36M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $10.85M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $12.32M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $13.79M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $18.05M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $14.38M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $14.25M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $14.12M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $13.99M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $14.89M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $14.57M 10-K · filed 2016-03-23 | $14.77M 10-K · filed 2015-03-09 |
| 2014-09-30 | $9.86M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $9.71M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $9.67M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $4.87M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $4.84M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $4.82M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $4.79M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $3.77M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |